Snowball logo
logo
ABBV

AbbVie Inc.

ABBV34 β€’ SA
R$81.33+R$0.33Β  (0.41%)
πŸ’‘ Click on a row in the table to make it appear on the graph
πŸ“Š Compare financials of multiple companies on the same chart
This feature is available with our premium plans. Upgrade to unlock the full potential of Snowball Analytics and be on top of your investments!
20212022202320242025TTM
Revenue
Total revenue
10,087.210,982.611,193.69,118.361,16064,386
COGS
3,107.83,126.63,755.92,736.117,35717,518
Gross Profit
6,979.47,8567,437.76,382.243,80346,868
Operating Expenses & Income
Operating Income
3,217.33,427.42,628.91,478.915,07517,905
Total Operating Expenses
6,697.27,423.48,564.77,639.446,08546,481
R&D Expenses
1,271.61,231.61,581.62,070.49,0969,714
Selling General & Admin Expenses
2,153.32,811.42,6132,371.114,01014,674
Earnings from Continuing Operations
Interest Expense
(427.9)(421.9)(458.3)(454.5)(2,893)(2,916)
Interest Income
437.1414.7377.13532,6851,492
Income Tax Expense
258.5308.7----
Net Income
Net Income
2,071.82,239.11,002.1692.44,2266,310
Supplemental
EBIT
3,749.94,279.6----
EBITDA
2,759.43,559.2----
In millions of BRL, except % and values per 1 share